Clinical effect of a weight loss program for female infertility patients

Clinical effect of a weight loss program for female infertility patients - Clinical effect of a weight loss program for female infertility patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049268

Enrollment

100

Registered

2022-11-01

Start date

2022-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility

Interventions

Weight loss program including exercise therapy and diet therapy for 3 months

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female patients with a BMI of 23 or higher who visited fertility clinic

Exclusion criteria

Exclusion criteria: Those who cannot obtain consent, or those who are deemed unsuitable by the research director/co-investigator

Design outcomes

Primary

Measure	Time frame
anti-Mullerian hormone (AMH) after a weight loss program	—

Secondary

Measure	Time frame
HOMA-R, HbA1c, triglyceride, HDL cholesterol, LDL cholesteroll, FSH, maturation rate of retrieved oocytes, fertilization rate, good blastocyst rate, euploid blastocyst rate, clinical pregnancy rate, miscarriage rate, live birth rate before and after the program	—

Countries

Japan

Contacts

Public ContactTomomoto Ishikawa

Reproduction Clinic Osaka Reproduction Clinic Osaka

tishikawa@reposaka.jp06-6136-3344

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026